BRIEF—Bob Hugin steps down from Celgene board of directors

Long-time Celgene executive chairman Bob Hugin has retired, the firm has announced. Chief executive Mark Alles will take on the new role of chairman.

Mr Hugin said: “It has been a tremendous privilege to be part of Celgene’s growth and to help advance Celgene’s mission to serve patients through scientific breakthroughs in the treatment of cancer and other serious medical conditions.”

After joining the firm as chief financial officer in 1999, Mr Hugin served as president and chief operating officer from 2006 to 2010, and CEO from 2010 until 2016.